ES8608872A1 - Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada. - Google Patents

Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.

Info

Publication number
ES8608872A1
ES8608872A1 ES536167A ES536167A ES8608872A1 ES 8608872 A1 ES8608872 A1 ES 8608872A1 ES 536167 A ES536167 A ES 536167A ES 536167 A ES536167 A ES 536167A ES 8608872 A1 ES8608872 A1 ES 8608872A1
Authority
ES
Spain
Prior art keywords
endotoxin
extract
pyridine
treatment
piridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES536167A
Other languages
English (en)
Spanish (es)
Other versions
ES536167A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ribi Immunochem Research Inc
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of ES536167A0 publication Critical patent/ES536167A0/es
Publication of ES8608872A1 publication Critical patent/ES8608872A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES536167A 1983-09-23 1984-09-21 Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada. Expired ES8608872A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
ES536167A0 ES536167A0 (es) 1986-07-16
ES8608872A1 true ES8608872A1 (es) 1986-07-16

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536167A Expired ES8608872A1 (es) 1983-09-23 1984-09-21 Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.

Country Status (23)

Country Link
US (1) US4663306A (cg-RX-API-DMAC7.html)
JP (1) JPS60120817A (cg-RX-API-DMAC7.html)
KR (1) KR870000843B1 (cg-RX-API-DMAC7.html)
AT (1) AT385659B (cg-RX-API-DMAC7.html)
AU (1) AU566234B2 (cg-RX-API-DMAC7.html)
BE (1) BE900650A (cg-RX-API-DMAC7.html)
CA (1) CA1244765A (cg-RX-API-DMAC7.html)
CH (1) CH664897A5 (cg-RX-API-DMAC7.html)
DE (1) DE3434766C2 (cg-RX-API-DMAC7.html)
DK (1) DK446684A (cg-RX-API-DMAC7.html)
ES (1) ES8608872A1 (cg-RX-API-DMAC7.html)
FI (1) FI843716L (cg-RX-API-DMAC7.html)
FR (1) FR2552326B1 (cg-RX-API-DMAC7.html)
GB (1) GB2149301B (cg-RX-API-DMAC7.html)
HU (1) HU192585B (cg-RX-API-DMAC7.html)
IL (1) IL73034A (cg-RX-API-DMAC7.html)
IN (1) IN157240B (cg-RX-API-DMAC7.html)
IT (1) IT1179444B (cg-RX-API-DMAC7.html)
NL (1) NL8402902A (cg-RX-API-DMAC7.html)
NO (1) NO843776L (cg-RX-API-DMAC7.html)
NZ (1) NZ209635A (cg-RX-API-DMAC7.html)
SE (1) SE8404707L (cg-RX-API-DMAC7.html)
ZA (1) ZA847405B (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
ATE210989T1 (de) * 1993-08-27 2002-01-15 Vetrepharm Inc Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
CA2299548C (en) 1997-08-05 2009-12-29 Bioniche Inc. Composition and method for regulating cell proliferation and cell death
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
KR100628007B1 (ko) 1998-07-16 2006-09-26 이치로 아즈마 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제
JP4772245B2 (ja) * 1999-12-13 2011-09-14 バイオニケ ライフ サイエンシーズ インコーポレイテッド 治療上有用な合成オリゴヌクレオチド
CA2395493C (en) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
JP5106736B2 (ja) * 2000-07-11 2012-12-26 アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト 臓器線維形成に対するパラポックスウイルスｏｖｉｓ株の使用
KR100820521B1 (ko) * 2002-03-05 2008-04-07 셀 메디신 가부시키가이샤 고체화 조직 면역아쥬반트
AU2003254792A1 (en) * 2002-08-02 2004-02-23 Sumitomo Pharmaceuticals Company, Limited Bacterial cell wall skeleton component preparaion
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
AU2003261624A1 (en) * 2003-09-05 2005-03-29 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
HK1214510A1 (zh) 2013-04-18 2016-07-29 Immune Design Corp. 用於癌症治疗的gla单一疗法
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
HUE071447T2 (hu) 2014-06-17 2025-08-28 Crown Laboratories Inc Genetikailag módosított baktériumok és eljárások baktériumok genetikai módosítására
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
EP3668957A4 (en) * 2017-08-17 2021-06-02 University of Delaware Furan based compositions and methods of making thereof
JP2023533202A (ja) 2020-06-23 2023-08-02 クラウン ラボラトリーズ，インコーポレイテッド プロバイオティクス皮膚製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (cg-RX-API-DMAC7.html) * 1972-06-20 1973-12-27
FR2269962B1 (cg-RX-API-DMAC7.html) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
SE8404707L (sv) 1985-03-24
SE8404707D0 (sv) 1984-09-20
IT1179444B (it) 1987-09-16
NZ209635A (en) 1989-01-27
BE900650A (fr) 1985-03-21
FI843716A7 (fi) 1985-03-24
ATA302384A (de) 1987-10-15
JPS6254775B2 (cg-RX-API-DMAC7.html) 1987-11-17
ZA847405B (en) 1985-05-29
FI843716A0 (fi) 1984-09-21
GB2149301B (en) 1988-06-22
ES536167A0 (es) 1986-07-16
HUT35521A (en) 1985-07-29
JPS60120817A (ja) 1985-06-28
KR870000843B1 (ko) 1987-04-25
NO843776L (no) 1985-03-25
IT8448894A0 (it) 1984-09-24
DE3434766A1 (de) 1986-04-30
IL73034A (en) 1988-11-15
GB2149301A (en) 1985-06-12
DE3434766C2 (de) 1987-05-14
CH664897A5 (de) 1988-04-15
FI843716L (fi) 1985-03-24
US4663306A (en) 1987-05-05
CA1244765A (en) 1988-11-15
AT385659B (de) 1988-05-10
IN157240B (cg-RX-API-DMAC7.html) 1986-02-15
FR2552326A1 (fr) 1985-03-29
AU566234B2 (en) 1987-10-15
KR850002404A (ko) 1985-05-13
AU3340084A (en) 1985-03-28
HU192585B (en) 1987-06-29
NL8402902A (nl) 1985-04-16
FR2552326B1 (fr) 1988-05-13
DK446684A (da) 1985-03-24
DK446684D0 (da) 1984-09-19
GB8423993D0 (en) 1984-10-31

Similar Documents

Publication Publication Date Title
ES8608872A1 (es) Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.
ES8101887A1 (es) Procedimiento para obtener una preparacion farmaceutica que comprende un glicorido cardiaco con un revertimiento de po- limero
CN106588665B (zh) 一种脂溶性咖啡酸脂肪酸结构油脂及其制备方法与应用
DE3585713D1 (de) Immunoverstaerker und verfahren zu ihrer herstellung.
IT7849866A0 (it) Procedimento per la produzione di esteri misti parzialmente neutralizzati di acido lattico acido citrico ed esteri parziali di acidi grassi e di glicerina
CH512835A (de) Verfahren zur Herstellung elektrischer Verbindungselemente und zu ihrer Befestigung an elektrischen Leitern sowie Vorrichtung zur Ausführung des Verfahrens
GB1461688A (en) Pharmaceutical compositions comprising an enzyme and substrate
GB724256A (en) Improvements in the production of esters of pyridine carboxylic acids
GB1427253A (en) Antilipemic composition containing unsaponifiable matter of soybean oil
ES8505665A1 (es) Procedimiento para preparar derivados acilaminofenolicos
CA937935A (en) Process for the preparation of benzimidazole-2-carbamic acid esters
DK286586A (da) Fremgangsmaade til separation og isolering af nosiheptid
YOKOKAWA Studies on the Oils of Basidiomycetes. IV. On the Oils of Masutake (Polyporus sulphureus, Fr.) and Kikurage (Auricularia auricula jadae, Quel)
GT196912430A (es) Proceso
AU438234B2 (en) PROCESS FORTHE PREPARATION OF BENZIMIDAZOLE CARBAMIC acid esters
IT1054501B (it) Processo per la preparazione di esteri del acido i.4 naftalendi carbossilico
BE764837A (fr) Nouveaux esters d'acide phosphorique, leur procede de preparation et leur application comme insectides acaricides et nematocides
AU1676170A (en) PROCESS FORTHE PREPARATION OF BENZIMIDAZOLE CARBAMIC acid esters
CA922572A (en) Method of preparing vegetable concentrate and concentrate thereby produced
JPS5398918A (en) Preparation of gamma-pyrone derivatives
AU446559B2 (en) Process forthe preparation of branched epoxyalkyl esters
JPS5575401A (en) Polysaccharide and preparation thereof
JPS5242853A (en) Process for preparation of dihalovinylcyclopropanecaboxylic acid ester s
AU1935970A (en) Process forthe preparation of branched epoxyalkyl esters
Stevan et al. Investigations on Extraction of Rat Plasma Phospholipids.